VIG ETF Factor Report

Validea's fundamental report designates Vanguard Div Appreciation ETF (VIG) as a Large-Cap Quality ETF with its largest sector being Technology and largest industry Biotechnology & Drugs. The ETF exhibits strong quality (95) and low volatility (92) factor scores, while value (41) and momentum (39) scores are comparatively lower. The report is based on Validea's analysis of investment strategies from historical market-beating investment gurus.

Analysis

Validea's fundamental report characterizes the Vanguard Div Appreciation ETF (VIG) as a Large-Cap Quality ETF. The fund's portfolio exhibits a significant concentration in the Technology sector, with Biotechnology & Drugs being its largest single industry exposure. An analysis of its major investing factors reveals a strong tilt towards Quality, with a score of 95 out of 99, and Low Volatility, scoring 92. Conversely, VIG shows considerably lower exposure to Value (score of 41) and Momentum (score of 39). This factor profile suggests the ETF is primarily composed of companies perceived as stable and financially sound, rather than those currently undervalued or exhibiting strong recent price trends. The analysis methodology is rooted in Validea's research, which emulates the published strategies of historically successful investment managers.

Key Decisions for Investors

• Investors seeking exposure to high-quality, large-cap equities with a defensive characteristic due to low volatility may find VIG suitable, as indicated by its factor scores of 95 for Quality and 92 for Low Volatility.
• Those prioritizing Value or Momentum strategies should note VIG's lower scores of 41 and 39 in these respective factors, suggesting it may not align with investment objectives focused on these areas.
• Consider the ETF's significant allocation to the Technology sector and Biotechnology & Drugs industry for portfolio diversification and ensure it aligns with overall sector exposure targets.